Sahin, G. Et Al. 2022. Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.. Journal of pharmaceutical sciences , vol.111, no.10 , 2652-2661.

Sahin, G., Akbal-Dagistan, Ö., Culha, M., Erturk, A., Basarir, N. S., Sancar, S., ... Yildiz-Pekoz, A.(2022). Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.. Journal of pharmaceutical sciences , vol.111, no.10, 2652-2661.

Sahin, Gokben Et Al. "Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.," Journal of pharmaceutical sciences , vol.111, no.10, 2652-2661, 2022

Sahin, Gokben Et Al. "Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.." Journal of pharmaceutical sciences , vol.111, no.10, pp.2652-2661, 2022

Sahin, G. Et Al. (2022) . "Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.." Journal of pharmaceutical sciences , vol.111, no.10, pp.2652-2661.

@article{article, author={Gokben Sahin Et Al. }, title={Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.}, journal={Journal of pharmaceutical sciences}, year=2022, pages={2652-2661} }